Division of Rheumatology, Department of Medicine, The University of Western Ontario, London, Ont., Canada.
Department of Microbiology and Immunology, The University of Western Ontario, London, Ont., Canada.
Semin Arthritis Rheum. 2018 Jun;47(6):900-906. doi: 10.1016/j.semarthrit.2017.11.001. Epub 2017 Nov 10.
Takayasu's arteritis (TAK) is a rare vasculitis affecting the large blood vessels with significant morbidity and mortality from ischemic complications. The objective of this meta-analysis is to determine the proportion of TAK patients with severe ischemic complications.
We performed a literature search using MEDLINE, EMBASE, and the Cochrane library from database inception to March 2016. We included articles that reported at least one severe ischemic complication. A random effects model with inverse-variance weighting was performed to estimate the pooled proportion of TAK subjects with ischemic complications.
In all, 35 studies met inclusion criteria, representing 3262 TAK patients. All studies were observational and of low to moderate quality. Mean age at symptom onset or at diagnosis ranged from 10 to 49 years and mean delay from symptom onset to diagnosis ranged from 2 months to 7.6 years. Study follow-up times were from 22 months to 17 years. The majority of studies had >70% female subjects. The pooled prevalence of stroke in TAK was 8.9% (95% CI: 7.0-10.9%) and of MI was 3.4% (95% CI: 2.1-4.8%) at any time during the disease course. There was moderate-to-severe heterogeneity across the studies (stroke: I = 64.9%; MI: I = 74.0%). Other ischemic complications were inconsistently reported.
Stroke and MI are common in TAK patients. Further studies are needed to identify predictors and preventative measures for severe ischemic events in TAK patients.
多发性大动脉炎(TAK)是一种罕见的大血管血管炎,其缺血性并发症具有较高的发病率和死亡率。本荟萃分析旨在确定 TAK 患者发生严重缺血性并发症的比例。
我们检索了 MEDLINE、EMBASE 和 Cochrane 图书馆自建库以来至 2016 年 3 月的文献。纳入至少报告了一种严重缺血性并发症的文章。采用随机效应模型进行逆方差加权,以估计 TAK 患者发生缺血性并发症的合并比例。
共有 35 项研究符合纳入标准,共纳入 3262 例 TAK 患者。所有研究均为观察性研究,质量为低到中等。发病症状或诊断时的平均年龄为 10 至 49 岁,从发病症状到诊断的平均延迟时间为 2 个月至 7.6 年。研究随访时间从 22 个月到 17 年不等。大多数研究中女性患者比例>70%。TAK 患者中任何时间发生卒中的合并患病率为 8.9%(95%CI:7.0%-10.9%),心肌梗死的合并患病率为 3.4%(95%CI:2.1%-4.8%)。研究间存在中度至高度异质性(卒中:I²=64.9%;心肌梗死:I²=74.0%)。其他缺血性并发症的报告不一致。
卒中和心肌梗死在 TAK 患者中较为常见。需要进一步研究以确定 TAK 患者严重缺血事件的预测因素和预防措施。